Hydrogen/deuterium exchange mass spectrometry for probing higher order structure of protein therapeutics: methodology and applications.

The higher order structure of protein therapeutics can be interrogated with hydrogen/deuterium exchange mass spectrometry (HDX-MS). HDX-MS is now a widely used tool in the structural characterization of protein therapeutics. In this review, HDX-MS based workflows designed for protein therapeutic discovery and development processes are presented, focusing on the specific applications of epitope mapping for protein/drug interactions and biopharmaceutical comparability studies. Future trends in the application of HDX-MS in protein therapeutics characterization are also described.

[1]  D. Suckau,et al.  Molecular epitope identification by limited proteolysis of an immobilized antigen-antibody complex and mass spectrometric peptide mapping. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Wim Jiskoot,et al.  A Role for Protein Misfolding in Immunogenicity of Biopharmaceuticals* , 2007, Journal of Biological Chemistry.

[3]  Alain Van Dorsselaer,et al.  Characterization of therapeutic antibodies and related products. , 2013, Analytical chemistry.

[4]  V. Katta,et al.  Conformational changes in proteins probed by hydrogen-exchange electrospray-ionization mass spectrometry. , 1991, Rapid communications in mass spectrometry : RCM.

[5]  M. J. Chalmers,et al.  Automated Hydrogen/Deuterium Exchange Electron Transfer Dissociation High Resolution Mass Spectrometry Measured at Single-Amide Resolution , 2012, Journal of The American Society for Mass Spectrometry.

[6]  Zhongqi Zhang,et al.  Determination of amide hydrogen exchange by mass spectrometry: A new tool for protein structure elucidation , 1993, Protein science : a publication of the Protein Society.

[7]  W. Duckworth,et al.  Recombinant DNA technology in the treatment of diabetes: insulin analogs. , 2001, Endocrine reviews.

[8]  S. Berkowitz,et al.  Characterization of IgG1 Conformation and Conformational Dynamics by Hydrogen/Deuterium Exchange Mass Spectrometry. , 2009, Analytical chemistry.

[9]  John R Engen,et al.  Hydrogen Exchange Mass Spectrometry: Are We Out of the Quicksand? , 2012, Journal of The American Society for Mass Spectrometry.

[10]  Ole N Jensen,et al.  Protein hydrogen exchange measured at single-residue resolution by electron transfer dissociation mass spectrometry. , 2009, Analytical chemistry.

[11]  S. Berkowitz,et al.  Conformation and dynamics of biopharmaceuticals: Transition of mass spectrometry-based tools from academe to industry , 2010, Journal of the American Society for Mass Spectrometry.

[12]  M. Gross,et al.  Protein and peptide mass spectrometry in drug discovery , 2012 .

[13]  J. J. Rosa,et al.  An experimental procedure for increasing the structural resolution of chemical hydrogen-exchange measurements on proteins: application to ribonuclease S peptide. , 1979, Journal of molecular biology.

[14]  John R. Engen,et al.  Analysis of protein conformation and dynamics by hydrogen/deuterium exchange MS. , 2009, Analytical chemistry.

[15]  K. Reddy,et al.  Controlled-Release, Pegylation, Liposomal Formulations: New Mechanisms in the Delivery of Injectable Drugs , 2000, The Annals of pharmacotherapy.

[16]  Y. Yu,et al.  Accessing the reproducibility and specificity of pepsin and other aspartic proteases. , 2013, Biochimica et biophysica acta.

[17]  Lars Konermann,et al.  Hydrogen exchange mass spectrometry for studying protein structure and dynamics. , 2011, Chemical Society reviews.

[18]  L. Konermann,et al.  Pulsed hydrogen/deuterium exchange MS/MS for studying the relationship between noncovalent protein complexes in solution and in the gas phase after electrospray ionization. , 2006, Analytical chemistry.

[19]  L Mayne,et al.  Protein folding studied using hydrogen-exchange labeling and two-dimensional NMR. , 1992, Annual review of biophysics and biomolecular structure.

[20]  L. Mayne,et al.  Effect of antibody binding on protein motions studied by hydrogen-exchange labeling and two-dimensional NMR. , 1992, Biochemistry.

[21]  David C Schriemer,et al.  Discovery and characterization of the laulimalide-microtubule binding mode by mass shift perturbation mapping. , 2010, Chemistry & biology.

[22]  C. Borchers,et al.  Electron capture dissociation of electrosprayed protein ions for spatially resolved hydrogen exchange measurements. , 2008, Journal of the American Chemical Society.

[23]  Chris Bailey-Kellogg,et al.  Reducing Mass Degeneracy in SAR by MS by Stable Isotopic Labeling , 2000, J. Comput. Biol..

[24]  P. Haris,et al.  The conformational analysis of peptides using fourier transform IR spectroscopy , 1995, Biopolymers.

[25]  Zhongqi Zhang,et al.  Comparison of continuous and pulsed labeling amide hydrogen exchange/mass spectrometry for studies of protein dynamics , 1999, Journal of the American Society for Mass Spectrometry.

[26]  A HVIDT,et al.  Exchange of hydrogen atoms in insulin with deuterium atoms in aqueous solutions. , 1954, Biochimica et biophysica acta.

[27]  Ole N Jensen,et al.  Electron transfer dissociation facilitates the measurement of deuterium incorporation into selectively labeled peptides with single residue resolution. , 2008, Journal of the American Chemical Society.

[28]  Kasper D Rand,et al.  Electron capture dissociation proceeds with a low degree of intramolecular migration of peptide amide hydrogens. , 2008, Journal of the American Chemical Society.

[29]  Igor A Kaltashov,et al.  Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics. , 2012, Biotechnology advances.

[30]  I. Kaltashov,et al.  Impact of oxidation on protein therapeutics: Conformational dynamics of intact and oxidized acid‐β‐glucocerebrosidase at near‐physiological pH , 2010, Protein science : a publication of the Protein Society.

[31]  P. Roepstorff,et al.  Intramolecular migration of amide hydrogens in protonated peptides upon collisional activation. , 2005, Journal of the American Chemical Society.

[32]  S. Tuske,et al.  Epitope mapping by amide hydrogen/deuterium exchange coupled with immobilization of antibody, on-line proteolysis, liquid chromatography and mass spectrometry. , 2009, Rapid communications in mass spectrometry : RCM.

[33]  B. Pramanik,et al.  Characterization of Impurities and Degradants Using Mass Spectrometry: Pramanik/Impurities and Degradants Using MS , 2011 .

[34]  Markus A. Lill,et al.  A Medicinal Chemist's Guide to Molecular Interactions , 2013 .

[35]  John R Engen,et al.  High-speed and high-resolution UPLC separation at zero degrees Celsius. , 2008, Analytical chemistry.

[36]  Lihua Huang,et al.  Determination of the mechanism of action of anti-FasL antibody by epitope mapping and homology modeling. , 2009, Biochemistry.

[37]  John T. Powers,et al.  Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors , 2010, Nature.

[38]  G. Li Pira,et al.  High Throughput T Epitope Mapping and Vaccine Development , 2010, Journal of biomedicine & biotechnology.

[39]  S. Brier,et al.  Use of hydrogen/deuterium exchange mass spectrometry and mutagenesis as a tool to identify the binding region of inhibitors targeting the human mitotic kinesin Eg5. , 2006, Rapid communications in mass spectrometry : RCM.

[40]  Virgil L. Woods,et al.  Fluoroketone Inhibition of Ca2+-Independent Phospholipase A2 through Binding Pocket Association Defined by Hydrogen/Deuterium Exchange and Molecular Dynamics , 2012, Journal of the American Chemical Society.

[41]  J. R. Engen,et al.  Analysis of protein complexes with hydrogen exchange and mass spectrometry. , 2003, The Analyst.

[42]  B. Warrack,et al.  Characterization of protein therapeutics by mass spectrometry: recent developments and future directions. , 2011, Drug discovery today.

[43]  A. Brock,et al.  Fragmentation hydrogen exchange mass spectrometry: a review of methodology and applications. , 2012, Protein expression and purification.

[44]  Deirdre Murphy Piedmonte,et al.  Formulation of Neulasta (pegfilgrastim). , 2008, Advanced drug delivery reviews.

[45]  S. Berkowitz,et al.  Conformational comparability of factor IX-Fc fusion protein, factor IX, and purified Fc fragment in the absence and presence of calcium. , 2012, Journal of pharmaceutical sciences.

[46]  A. Hvidt,et al.  The kinetics of the deuterium exchange of insulin with D2O; an amendment. , 1955, Biochimica et Biophysica Acta.

[47]  Y. Yu,et al.  Using Hydrogen/Deuterium Exchange Mass Spectrometry to Study Conformational Changes in Granulocyte Colony Stimulating Factor upon PEGylation , 2012, Journal of The American Society for Mass Spectrometry.

[48]  S. Berkowitz,et al.  The utility of hydrogen/deuterium exchange mass spectrometry in biopharmaceutical comparability studies. , 2011, Journal of pharmaceutical sciences.

[49]  Qian Zhang,et al.  Epitope mapping of a 95 kDa antigen in complex with antibody by solution-phase amide backbone hydrogen/deuterium exchange monitored by Fourier transform ion cyclotron resonance mass spectrometry. , 2011, Analytical chemistry.

[50]  J A Wells,et al.  Dissecting the energetics of an antibody‐antigen interface by alanine shaving and molecular grafting , 1994, Protein science : a publication of the Protein Society.

[51]  A. P. Chapman,et al.  PEGylated antibodies and antibody fragments for improved therapy: a review. , 2002, Advanced drug delivery reviews.

[52]  Nicola Clementi,et al.  Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools. , 2013, Drug discovery today.

[53]  Guodong Chen,et al.  Hydrogen/Deuterium Exchange Mass Spectrometry for Protein Higher-Order Structure Characterization , 2013 .

[54]  F. Davis,et al.  Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. , 1977, The Journal of biological chemistry.

[55]  John R. Engen,et al.  Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars , 2012, Nature Reviews Drug Discovery.

[56]  L. Jin,et al.  High resolution functional analysis of antibody-antigen interactions. , 1992, Journal of molecular biology.

[57]  Janice M. Reichert,et al.  Marketed therapeutic antibodies compendium , 2012, mAbs.

[58]  F. Felici,et al.  Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen , 2013, Proceedings of the National Academy of Sciences.

[59]  S. Tuske,et al.  Mapping of discontinuous conformational epitopes by amide hydrogen/deuterium exchange mass spectrometry and computational docking , 2012, Journal of molecular recognition : JMR.

[60]  T. Wales,et al.  Hydrogen exchange mass spectrometry for the analysis of protein dynamics. , 2006, Mass spectrometry reviews.

[61]  G. Shaw,et al.  Folding kinetics of the S100A11 protein dimer studied by time-resolved electrospray mass spectrometry and pulsed hydrogen-deuterium exchange. , 2006, Biochemistry.

[62]  Janice M. Reichert,et al.  Which are the antibodies to watch in 2013? , 2013, mAbs.

[63]  R. Rappuoli,et al.  The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens. , 2012, Vaccine.